Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Inflammatory Bowel Diseases|November 21, 2007
Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype statusSilke Schmechel, Astrid Konrad, Julia Diegelmann, et al.
Plos One|April 8, 2017
Functional Toll-Like Receptor (TLR)2 polymorphisms in the susceptibility to inflammatory bowel diseaseHelga Paula Török, Victor Bellon, Astrid Konrad, et al.
European Journal of Gastroenterology & Hepatology|November 14, 2007
Resistin is an inflammatory marker of inflammatory bowel disease in humansAstrid Konrad, Michael Lehrke, Veronika Schachinger, et al.
Inflammatory Bowel Diseases|August 12, 2015
Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype StatusJohannes Stallhofer, Matthias Friedrich, Astrid Konrad-Zerna, et al.
Inflammatory Bowel Diseases|January 9, 2007
Apolipoprotein A-IV is an independent predictor of disease activity in patients with inflammatory bowel diseaseUli C Broedl, Veronika Schachinger, Arno Lingenhel, et al.
The American Journal of Gastroenterology|January 13, 2006
Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease PhenotypeStephan Brand, Katrin Hofbauer, Julia Dambacher, et al.
Inflammatory Bowel Diseases|June 24, 2005
The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's diseaseStephan Brand, Tanja Staudinger, Fabian Schnitzler, et al.
Inflammatory Bowel Diseases|December 20, 2007
Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBDJulia Seiderer, Ira Elben, Julia Diegelmann, et al.
Inflammatory Bowel Diseases|January 9, 2007
Macrophage migration inhibitory factor (MIF) -173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's diseaseJulia Dambacher, Tanja Staudinger, Julia Seiderer, et al.
The American Journal of Gastroenterology|March 6, 2009
rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German populationJürgen Glas, Julia Seiderer, Giulia Pasciuto, et al.
Pageof 3